Liver diseases and clinical pharmacology. 3. Clinical pharmacology of interferon and ribavirin affecting treatment result of chronic hepatitis C.
نویسندگان
چکیده
منابع مشابه
EFFICACY AND SAFETY OF COMBINATION THERAPY OF INTERFERON-ALPHA 2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C
Introduction: The aim of this study is to assess the therapeutic efficacy and safety of a particular brand of IFN alpha (PDferon B®) in combination with ribavirin (RlBA) on Iranian patients with chronic hepatitis C (CHC). The addition of RIBA to the standard treatment with interferon (IFN) alpha led to an improvement in sustained virologic response (SVR) from less than 20% with IFN monother...
متن کاملCryoglobulinemia in chronic hepatitis C: clinical aspects and response to treatment with interferon alpha and ribavirin.
INTRODUCTION The main extra-hepatic manifestation of hepatitis C is mixed cryoglobulinemia (MC). The aim of this study was to evaluate its prevalence among patients with chronic hepatitis C (CHC), to correlate its presence to host and virological variables and to the response to combined therapy with interferon-alpha and ribavirin. CASUISTIC AND METHODS 202 CHC naive patients (136 with chroni...
متن کاملTreatment of chronic hepatitis-C with standard interferon and ribavirin.
BACKGROUND The prevalence of hepatitis-C is on the rise in Pakistan. Treatment of chronic hepatitis-C with pegylated interferon is expensive as compared to standard interferon. The objective of the study was to find out the end treatment response rate with standard interferon and ribavirin. METHODOLOGy: This case series study was conducted in Ayub Teaching Hospital Abbottabad.and Orush General ...
متن کاملClinical Pharmacology of Ceftazidime in Neonates: Effects and Pharmacokinetics
Ceftazidime is a valuable third-generation bactericidal cephalosporin. Ceftazidime inhibits the biosynthesis of bacterial cell peptidoglycan, causing inhibition of bacterial growth or cell lyses and death. Common nosocomial gram-negative organisms susceptible to ceftazidime include Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria, Moraxella catarrhalis, Proteus mirabil...
متن کاملClinical Pharmacology of Ciprofloxacin in Neonates: Effects and Pharmacokinetics
Ciprofloxacin is the most commonly used fluoroquinolone. Ciprofloxacin is prescribed for 1 in 44 Americans. Ciprofloxacin is a broad-spectrum bactericidal antibiotic, effective against both gram-positive and gram-negative bacteria, being especially active against the Enterobacteriacae, including many microorganisms resistant to penicillins, cephalosporins and aminoglycosides, and also is effect...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
سال: 2005
ISSN: 1882-8272,0388-1601
DOI: 10.3999/jscpt.36.5_235